In adrenocortical carcinoma (ACC) cells, curcumin compels tumor cells to depend on glutamine metabolism for compensatory adaptation by upregulating the expression of SLC1A5 and GLS1. This evidence concerns the gene SLC1A5 and adrenal cortex carcinoma.